首页> 外文期刊>Scandinavian journal of urology and nephrology >Relationship between uremic toxins and oxidative stress in patients with chronic renal failure.
【24h】

Relationship between uremic toxins and oxidative stress in patients with chronic renal failure.

机译:慢性肾功能衰竭患者尿毒症毒素与氧化应激的关系。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: Uremic toxins play a critical role in the manifestation of the uremic syndrome. This is a consequence of retention of such substances in chronic renal failure patients and interactions between them. To date >100 uremic compounds have been discovered. The aim of this study was to elucidate potential relationships between N-methyl-2-pyridone-5-carboxamide (Me2PY) and N-methyl-4-pyridone-5-carboxamide (Me4PY), two uremic compounds, and different parameters of oxidative stress. MATERIAL AND METHODS: Forty-three non-dialyzed patients at the Nephrological Outpatients Clinic of Gdansk were enrolled and divided into two groups: (i) 20 patients with a mean estimated glomerular filtration rate (eGFR) of 22.7 ml/min/1.73 m(2); and (ii) 23 patients with a mean eGFR of 12.4 ml/min/1.73 m(2). In both groups, the plasma concentrations of uremic toxins (Me2PY, Me4PY, creatinine), malonyldialdehyde (MDA) and carbonyl groups and the erythrocyte concentration of glutathione (GSH) were analyzed. Correlations between uremic toxins and oxidative stress markers were calculated using Pearson's correlation. RESULTS: We observed significant correlations between serum creatinine and Me2PY (r=0.68; p=0.00001), eGFR and Me2PY (r=-0.55; p=0.00001), Me4PY and serum creatinine (r=0.64, p=0.00001), Me4PY and eGFR (r=-0.59; p=0.00008), MDA and Me2PY (r=0.42; p=0.006), MDA and Me4PY (r=0.38; p=0.02), GSH and Me2PY (r=-0.37; p=0.02) and GSH and Me4PY (r=-0.46; p=0.005), and in particular in patients with severe renal impairment. CONCLUSIONS: We conclude that there is a relationship between the novel uremic toxins described and oxidative stress markers. However, elucidation of the exact pathogenetic links requires further detailed studies.
机译:目的:尿毒症毒素在尿毒症综合征的表现中起关键作用。这是这些物质在慢性肾衰竭患者中保留以及它们之间相互作用的结果。迄今为止,已经发现了100多种尿毒症化合物。这项研究的目的是阐明N-甲基-2-吡啶酮-5-甲酰胺(Me2PY)和N-甲基-4-吡啶酮-5-甲酰胺(Me4PY),两种尿毒症化合物以及不同的氧化参数之间的潜在关系强调。材料与方法:纳入格但斯克肾脏门诊诊所的43例非透析患者,分为两组:(i)20例平均估计肾小球滤过率(eGFR)为22.7 ml / min / 1.73 m( 2); (ii)23例平均eGFR为12.4 ml / min / 1.73 m(2)的患者。在两组中,分析了血浆尿毒症毒素(Me2PY,Me4PY,肌酐),丙二酰二醛(MDA)和羰基的浓度以及谷胱甘肽(GSH)的红细胞浓度。尿毒症毒素和氧化应激标志物之间的相关性使用皮尔森相关性进行了计算。结果:我们观察到血清肌酐和Me2PY(r = 0.68; p = 0.00001),eGFR和Me2PY(r = -0.55; p = 0.00001),Me4PY和血清肌酐(r = 0.64,p = 0.00001),Me4PY之间存在显着相关性和eGFR(r = -0.59; p = 0.00008),MDA和Me2PY(r = 0.42; p = 0.006),MDA和Me4PY(r = 0.38; p = 0.02),GSH和Me2PY(r = -0.37; p = 0.02)和GSH和Me4PY(r = -0.46; p = 0.005),尤其是在严重肾功能不全的患者中。结论:我们得出结论,所描述的新型尿毒症毒素与氧化应激标记物之间存在关联。但是,确切的致病联系的阐明需要进一步的详细研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号